Xanthic Biopharma Inc. President, Gary Galitsky and Board Member, Dr. Gunther Hintz, Advance Cannabis Opportunity In Thailand

Xanthic Biopharma Inc. (CSE:xTHC) (formerly Aurquest Resources Inc.) ("Xanthic" or the "Company") is pleased to announce two of its executives,...

Dr. Peter Tolias, PhD Joins PUF Ventures’ Advisory Board

PUF Ventures Inc. (CSE:PUF, Frankfurt:PU3, OTCPK:PUFXF) ("PUF" or the "Company"), an advanced Access to Cannabis for Medical Purposes Regulations ("ACMPR")...

Illumina and Loxo Oncology Form Collaboration, Share Prices Increase

Illumina and Loxo have teamed up to develop and commercialize a multi-gene panel for broad tumor profiling for cancer indications.

Loxo Oncology and Illumina to Partner on Developing Next-Generation Sequencing-Based Pan-Cancer Companion Diagnostics

Loxo Oncology (Nasdaq:LOXO) and Illumina (Nasdaq:ILMN) announced a global strategic partnership to develop and commercialize a multi-gene panel for broad...

What is Oncology Investing?

What is oncology investing? This sector can be intimidating for investors first getting into the space — here's a brief breakdown...

XOMA Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update

XOMA (Nasdaq:XOMA), a pioneer in the discovery, development and licensing of therapeutic antibodies, today announced its fourth quarter and full...

Revive Therapeutics Advances Research Program of Cannabinoid-Based Therapies Targeting Liver Diseases

Revive Therapeutics Ltd. ("Revive" or the "Company") (TSX VENTURE:RVV) (OTCQB:RVVTF), a company focused on the research, development and commercialization of...